Inflammation via the Fractalkine (CX3CL1)/CX3CR1 Pathway Is Distinct From the TNF Pathway in Murine Colitis Model

被引:0
|
作者
Motoi, Sotaro
Ohkuro, Masayoshi
Ikeda, Wataru
Hamaguchi, Akiko
Muramoto, Kenzo
Sato, Toshitaka
Yasuda, Nobuyuki
Kajiwara, Akiharu
Kawano, Tetsu
Imai, Toshio
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1682
引用
收藏
页码:S684 / S684
页数:1
相关论文
共 50 条
  • [21] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Wojdasiewicz, Piotr
    Poniatowski, Lukasz A.
    Kotela, Andrzej
    Deszczynski, Jaroslaw
    Kotela, Ireneusz
    Szukiewicz, Dariusz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (05) : 395 - 403
  • [22] EVALUATION OF THE ROLE OF FRACTALKINE CHEMOKINE CX3CL1 AND ITS RECEPTOR CX3CR1 IN INFLAMMATORY MYOPATHIES
    Colafrancesco, S.
    Priori, R.
    Astorri, E.
    Scrivo, R.
    D'Amati, G.
    Giordano, C.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 568 - 568
  • [23] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Piotr Wojdasiewicz
    Łukasz A. Poniatowski
    Andrzej Kotela
    Jarosław Deszczyński
    Ireneusz Kotela
    Dariusz Szukiewicz
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 395 - 403
  • [24] The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
    Pawelec, Paulina
    Ziemka-Nalecz, Malgorzata
    Sypecka, Joanna
    Zalewska, Teresa
    CELLS, 2020, 9 (10) : 1 - 17
  • [25] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
    Limatola, Cristina
    Ransohoff, Richard M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [26] The CX3CL1/CX3CR1 Reprograms Glucose Metabolism Through HIF-1 Pathway in Pancreatic Adenocarcinoma
    Ren, He
    Zhao, Tiansuo
    Sun, Junwei
    Wang, Xiuchao
    Liu, Jingcheng
    Gao, Song
    Yu, Ming
    Hao, Jihui
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (11) : 2603 - 2611
  • [27] Role of the chemokine fractalkine (CX3CL1) and its receptor CX3CR1 in skeletal metastasis from prostate cancer
    Jamieson, Whitney L.
    Fox, Julia A.
    Fatatis, Alessandro
    CANCER RESEARCH, 2006, 66 (08)
  • [28] Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
    Szukiewicz, Dariusz
    Kochanowski, Jan
    Pyzlak, Michal
    Szewczyk, Grzegorz
    Stangret, Aleksandra
    Mittal, Tarun Kumar
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [29] Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican, Sarah
    Griffin, Matthew D.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] The Effect and Molecular Mechanism of Pancreatic Kallikrein in Painful Diabetic Neuropathy Based on CX3CL1/CX3CR1 Pathway
    Xiang, Xu
    Hui, Jin
    Lan, Xu
    DIABETES, 2018, 67